Table of Contents Author Guidelines Submit a Manuscript
Journal of Pregnancy
Volume 2012 (2012), Article ID 257597, 11 pages
http://dx.doi.org/10.1155/2012/257597
Research Article

Use of Medicines with Unknown Fetal Risk among Parturient Women from the 2004 Pelotas Birth Cohort (Brazil)

1Programa de Pós-Graduação em Epidemiologia, Universidade Federal de Pelotas, Rua Marechal Deodoro, 1160, 3 Piso, 96020-220 Pelotas, RS, Brazil
2Programa de Pós-Graduação em Epidemiologia, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos, 2400, 2 Andar, 90035-003 Porto Alegre, RS, Brazil
3Departamento de Ciências Básicas da Saúde, Universidade Federal de Ciências da Saúde de Porto Alegre, Rua Sarmento Leite, 245, 90050-170, Porto Alegre, RS, Brazil

Received 8 September 2012; Revised 25 November 2012; Accepted 26 November 2012

Academic Editor: Riitta Luoto

Copyright © 2012 Andréa Dâmaso Bertoldi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. E. Andrade, J. H. Gurwitz, R. L. Davis et al., “Prescription drug use in pregnancy,” American Journal of Obstetrics and Gynecology, vol. 191, no. 2, pp. 398–407, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. M. K. Bakker, J. Jentink, F. Vroom, P. B. van den Berg, H. E. K. de Walle, and L. T. W. de Jong-Van den Berg, “Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands,” International Journal of Obstetrics and Gynaecology, vol. 113, no. 5, pp. 559–568, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Engeland, J. G. Bramness, A. K. Daltveit, M. Rønning, S. Skurtveit, and K. Furu, “Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106 000 pregnancies in Norway 2004–2006,” British Journal of Clinical Pharmacology, vol. 65, no. 5, pp. 653–660, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. R. C. Costa da Fonseca, E. da Fonseca, and G. Bergsten-Mendes, “Prevalence of drug use during pregnancy: a pharmacoepidemiological approach,” Revista de Saude Publica, vol. 36, no. 2, pp. 205–212, 2002. View at Google Scholar · View at Scopus
  5. J. J. Gagne, V. Maio, V. Berghella, D. Z. Louis, and J. S. Gonnella, “Prescription drug use during pregnancy: a population-based study in Regione Emilia-Romagna, Italy,” European Journal of Clinical Pharmacology, vol. 64, no. 11, pp. 1125–1132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. L. T. C. Geib, E. F. Vargas Filho, D. Geib, D. I. Mesquita, and M. L. Nunes, “Prevalence and determinants of medication during pregnancy by risk class among mothers of liveborn infants,” Cadernos de Saude Publica, vol. 23, no. 10, pp. 2351–2362, 2007. View at Google Scholar · View at Scopus
  7. B. Kebede, T. Gedif, and A. Getachew, “Assessment of drug use among pregnant women in Addis Ababa, Ethiopia,” Pharmacoepidemiology and Drug Safety, vol. 18, no. 6, pp. 462–468, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Olesen, H. T. Sørensen, L. de Jong-Van den Berg et al., “Prescribing during pregnancy and lactation with reference to the Swedish classification system. A population-based study among Danish women,” Acta Obstetricia et Gynecologica Scandinavica, vol. 78, no. 8, pp. 686–692, 1999. View at Google Scholar · View at Scopus
  9. C. G. Osorio-de-Castro, V. L. Pepe, V. L. Luiza et al., “Prescribed and reported drug use during pregnancy,” Cadernos de Saúde Pública, vol. 20, supplement 1, pp. S73–82, 2004. View at Google Scholar · View at Scopus
  10. D. K. Rohra, N. Das, S. I. Azam et al., “Drug-prescribing patterns during pregnancy in the tertiary care hospitals of Pakistan: a cross sectional study,” BMC Pregnancy and Childbirth, vol. 8, article 24, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. R. Daw, G. E. Hanley, D. L. Greyson, and S. G. Morgan, “Prescription drug use during pregnancy in developed countries: a systematic review,” Pharmacoepidemiology and Drug Safety, vol. 20, no. 9, pp. 895–902, 2011. View at Publisher · View at Google Scholar
  12. G. Koren, A. Pastuszak, and S. Ito, “Drugs in Pregnancy,” New England Journal of Medicine, vol. 338, no. 16, pp. 1128–1137, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Bánhidy, R. Lowry, and A. Czeizel, “Risk and benefit of drug use during pregnancy,” International Journal of Medical Sciences, vol. 2, no. 3, pp. 100–106, 2005. View at Google Scholar
  14. H. Malm, J. Martikainen, T. Klaukka, and P. J. Neuvonen, “Prescription drugs during pregnancy and lactation—a Finnish register-based study,” European Journal of Clinical Pharmacology, vol. 59, no. 2, pp. 127–133, 2003. View at Google Scholar · View at Scopus
  15. Food and Drug Administration, “Code of Federal Regulations,” Title 21, Vol. 4, 2012, http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=201.
  16. I. Lacroix, C. Damase-Michel, M. Lapeyre-Mestre, and J. L. Montastruc, “Prescription of drugs during pregnancy in France,” Lancet, vol. 356, no. 9243, pp. 1735–1736, 2000. View at Google Scholar · View at Scopus
  17. A. Basgül, A. Akici, A. Uzuner et al., “Drug utilization and teratogenicity risk categories during pregnancy,” Advances in Therapy, vol. 24, no. 1, pp. 68–80, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Andrade, M. Raebel, A. Morse et al., “Use of prescription medications with a potential for fetal harm among pregnant women,” Pharmacoepidemiology and Drug Safety, vol. 15, no. 8, pp. 546–554, 2006. View at Google Scholar
  19. E. H. Riley, E. Fuentes-Afflick, R. A. Jackson et al., “Correlates of prescription drug use during pregnancy,” Journal of Women's Health, vol. 14, no. 5, pp. 401–409, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. J. R. Daw, B. Mintzes, M. R. Law, G. E. Hanley, and S. G. Morgan, “Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001–2006),” Clinical Therapeutics, vol. 34, no. 1, pp. 239–249, 2012. View at Google Scholar
  21. C. Irl and J. Hasford, “The PEGASUS project—a prospective cohort study for the investigation of drug use in pregnancy,” International Journal of Clinical Pharmacology and Therapeutics, vol. 35, no. 12, pp. 572–576, 1997. View at Google Scholar · View at Scopus
  22. H. Malm, J. Martikainen, T. Klaukka, and P. J. Neuvonen, “Prescription of hazardous drugs during pregnancy,” Drug Safety, vol. 27, no. 12, pp. 899–908, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. S. S. Mengue, E. P. Schenkel, B. B. Duncan, and M. I. Schmidt, “Drug use by pregnant women in six Brazilian cities,” Revista de Saude Publica, vol. 35, no. 5, pp. 415–420, 2001. View at Google Scholar · View at Scopus
  24. A. J. D. Barros, I. D. S. dos Santos, C. G. Victora et al., “The 2004 Pelotas birth cohort: methods and description,” Revista de Saude Publica, vol. 40, no. 3, pp. 402–413, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Klasco, “DRUGDEX System,” in Thomson MICROMEDEX, 2010. View at Google Scholar
  26. G. G. BRIGGS, R. K. FREEMAN, and S. J. YAFFE, Drugs in Pregnancy and Lactation, Lippincott Williams & Wilkins, Philadelphia, 9th edition, 2011.
  27. F. Haramburu, G. Miremont-Salamé, and N. Moore, “Good and bad drug prescription in pregnancy,” Lancet, vol. 356, no. 9243, p. 1704, 2000. View at Google Scholar · View at Scopus
  28. T. Yang, M. C. Walker, D. Krewski et al., “Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population,” Pharmacoepidemiology and Drug Safety, vol. 17, no. 3, pp. 270–277, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. L. T. de Jong-van den Berg, C. M. Waardenburg, F. M. Haaijer-Ruskamp, M. N. G. Dukes, and H. Wesseling, “Drug use in pregnancy: a comparative appraisal of data collecting methods,” European Journal of Clinical Pharmacology, vol. 45, no. 1, pp. 9–14, 1993. View at Google Scholar · View at Scopus
  30. A. D. Bertoldi, A. J. D. Barros, P. C. Hallal, and R. C. Lima, “Drug utilization in adults: prevalence and individuals determinants,” Revista de Saude Publica, vol. 38, no. 2, pp. 228–238, 2004. View at Google Scholar · View at Scopus
  31. P. Carrasco-Garrido, R. Jiménez-García, V. Hernández Barrera, and A. Gil de Miguel, “Predictive factors of self-medicated drug use among the Spanish adult population,” Pharmacoepidemiology and Drug Safety, vol. 17, no. 2, pp. 193–199, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Sans, G. Paluzie, T. Puig, L. Balana, and I. I. Balaguer-Vintro, “Prevalence of drug utilization in the adult population of Catalonia, Spain,” Gaceta Sanitaria, vol. 16, no. 2, pp. 121–130, 2002. View at Google Scholar
  33. K. S. Costa, M. B. A. de Barros, P. M. S. B. Francisco, C. L. G. César, M. Goldbaum, and L. Carandina, “Use of medication and associated factors: a population-based study in Campinas, São Paulo State, Brazil,” Cadernos de Saude Publica, vol. 27, no. 4, pp. 649–658, 2011. View at Google Scholar · View at Scopus
  34. V. Egen-Lappe and J. Hasford, “Drug prescription in pregnancy: analysis of a large statutory sickness fund population,” European Journal of Clinical Pharmacology, vol. 60, no. 9, pp. 659–666, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Wiffen, M. Mitchell, and M. Snelling, Oxford Handbook of Clinical Pharmacy Oxford, Oxford University Press, Oxford, UK, 2007.
  36. G. C. Guerra, A. Q. da Silva, L. B. Franca, P. M. Assuncao, R. X. Cabral, and A. A. Ferreira, “Drug use during pregnancy in Natal, Brazil,” Revista Brasileira de Ginecologia e Obstetrícia, vol. 30, no. 1, pp. 12–18, 2008. View at Google Scholar
  37. A. Addis, N. Magrini, and P. Mastroiacovo, “Drug use during pregnancy,” Lancet, vol. 357, no. 9258, p. 800, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. P. S. Shah and A. Ohlsson, “Effects of prenatal multimicronutrient supplementation on pregnancy outcomes: a meta-analysis,” Canadian Medical Association Journal, vol. 180, no. 12, pp. E99–E108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. B. A. Haider and Z. A. Bhutta, “Multiple-micronutrient supplementation for women during pregnancy,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD004905, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Damase-Michel, M. Lapeyre-Mestre, C. Moly, A. Fournié, and J. L. Montastruc, “Drug use during pregnancy: survey in 250 women consulting at a university hospital center,” Journal de Gynecologie Obstetrique et Biologie de la Reproduction, vol. 29, no. 1, pp. 77–85, 2000. View at Google Scholar · View at Scopus
  41. J. P. Peña-Rosas and F. E. Viteri, “Effects and safety of preventive oral iron or iron+folic acid supplementation for women during pregnancy,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD004736, 2009. View at Google Scholar · View at Scopus
  42. K. B. Feibus, “FDA's proposed rule for pregnancy and lactation labeling: improving maternal child health through well-informed medicine use,” Journal of Medical Toxicology, vol. 4, no. 4, pp. 284–288, 2008. View at Google Scholar · View at Scopus
  43. L. B. Holmes, “Human teratogens: update 2010,” Birth Defects Research Part A, vol. 91, no. 1, pp. 1–7, 2011. View at Publisher · View at Google Scholar · View at Scopus